Erudio Healtherudio.com
Drug
Selinexor trials: what clinicians said in public
No HCP commentary report on a trial studying selinexor yet. Erudio has found public clinician commentary on 5 clinical trials studying selinexor, including C-SMART, CERVINO, SADAL and SENTRY. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CERVINO NCT06158841 · AbbVie DeepView → | relapsed or refractory multiple myeloma | Phase 3 | Deep | View | |||
| SADAL NCT02227251 · Karyopharm Therapeutics Inc FocusedView → | relapsed/refractory diffuse large B-cell lymphoma | Phase 2 | Focused | View | |||
| SENTRY NCT04562389 · Karyopharm Therapeutics Inc FocusedView → | JAK inhibitor-naïve myelofibrosis | Phase 3 | Focused | View | |||
| C-SMART NCT04534725 · Peter MacCallum Cancer Centre, Australia FocusedView → | COVID-19 in cancer patients | Phase 3 | Focused | View | |||
| NCT05028348 NCT05028348 · European Myeloma Network B.V. FocusedView → | Not given | Phase 3 | Focused | View | |||